Neurogene Inc. (NGNE)
NASDAQ·Healthcare·Biotechnology
$29.20
+0.69%
Mkt Cap $418.59M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (13 analysts)
$69.00
Range $69.00 – $69.00
Implied Upside
+136.3%
Consensus $69.00 vs current $29.20
NASDAQ·Healthcare·Biotechnology
$29.20
+0.69%
Mkt Cap $418.59M
Buy
3
Hold
0
Sell
0
Price Target (13 analysts)
$69.00
Range $69.00 – $69.00
+136.3%
Consensus $69.00 vs current $29.20